Jury slaps J&J with $63M verdict in Motrin case; Pharma sales down 15% on Spanish cuts;

@FiercePharma: Pharma girds for battle against Medicaid-level rebates for 'dual eligibles.' Fought and won before, but this time? More | Follow @FiercePharma

@EricPFierce: Takeda and one of its contract manufacturers sanctioned by Japanese regulator. Plant ordered closed for 12 days. News | Follow @EricPFierce

@AlisonBFierce: 2012 marked the largest whooping cough outbreak in 50 years. A new vaccine-resistant strain may be to blame. Report | Follow @AlisonBFierce

> Johnson & Johnson ($JNJ) was hit with a $63 million jury verdict in a lawsuit over the Motrin painkiller, which was blamed for a young girl's case of Stevens-Johnson Syndrome. Report

> Almost all drugmakers operating in Spain say their sales there have fallen an average of 15% over the past two years because of government cost-cutting. Report

> Drugmakers vow to fight President Obama's latest calls for Medicaid-level rebates on drugs used by patients who are eligible for both Medicare and Medicaid. Report

> India's Dr. Reddy's Laboratories posted a larger-than-expected drop in quarterly profits as North American sales disappointed. Report

> Zydus Cadila won FDA approval for its version of the Takeda Pharmaceutical diabetes drug Actos. Report

Medical Device News

 @FierceMedDev: Special Report: R&D advances in cancer Dx. Special Report | Follow @FierceMedDev

 @MarkHFierce: Medtronic wins with new study that touts merit of DBS for early Parkinson's. More | Follow @MarkHFierce

 @DamianFierce: The medical device tax is particularly treacherous for small companies, Theragenics says. Article | Follow @DamianFierce

> Rigid FX cited for quality violations concerning orthopedic surgical device. Item

> Hospira back in FDA's sights over device manufacturing. Story

Biotech News

 @FierceBiotech: Sanofi rebuilds early-stage R&D strategy in thriving Boston/Cambridge hub. Story | Follow @FierceBiotech

@JohnCFierce: Gregoire exits Shire HGT one step ahead of new CEO's debut (any chance this is connected to new CEO selection?) Article | Follow @JohnCFierce

@RyanMFierce: Boehringer Ingelheim goes to Hungary for R&D software. Article | Follow @RyanMFierce

> Biotech startup scores $20M C round for OTC weight-loss product and diabetes med. Article

> Third Rock bankrolls cancer immunotherapy upstart with $47M A round. News

Pharma Manufacturing News

> Takeda, CMO hit with sanctions by Japanese regulator. More

> Baxter beefing up cytotoxic manufacturing. Story

> Sanofi again turns to Waterford plant for production solution. Report

> Hospira moves forward with two plants in India. Article

Vaccines News

> Study: Untreated depression decreased effectiveness of shingles vaccine. More

> New whooping cough strain may resist vaccine. Story

> PharmaJet needle-free injector nabs WHO nod. Article

> EMA: Intercell can market Ixiaro in EU. More

> GSK flu vaccine additive under the microscope. Report

And Finally... The use of emergency contraception by American women has more than doubled to 11% from 4% in 2002. Report (sub. req.)

Suggested Articles

Stephen Hahn, an oncologist who served as the chief medical officer for the MD Anderson Cancer Center, has secured Senate confirmation as FDA head.

As BMS searches for bright spots in its Opdivo-chemo combo fail from June, it’s zeroing in on squamous lung cancer patients who seemed to benefit.

The FDA's ad watchdog served its most serious violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world.